OrbusNeich Medical Group Holdings (HKSE:06929) EPS (Basic) : HK$0.37 (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is OrbusNeich Medical Group Holdings EPS (Basic)?

OrbusNeich Medical Group Holdings's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was HK$0.18. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.37.

OrbusNeich Medical Group Holdings's EPS (Diluted) for the six months ended in Jun. 2024 was HK$0.18. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.36.

OrbusNeich Medical Group Holdings's EPS without NRI for the six months ended in Jun. 2024 was HK$0.18. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was 0.37.

During the past 12 months, OrbusNeich Medical Group Holdings's average EPS without NRIGrowth Rate was 11.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 91.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, OrbusNeich Medical Group Holdings's highest 3-Year average EPS without NRI Growth Rate was 91.60% per year. The lowest was 40.40% per year. And the median was 66.00% per year.

OrbusNeich Medical Group Holdings EPS (Basic) Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings EPS (Basic) Chart

OrbusNeich Medical Group Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

0.07

-0.06

0.25

0.43

OrbusNeich Medical Group Holdings Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EPS (Basic)	Get a 7-Day Free Trial				0.08	0.10	0.24	0.19	0.18

OrbusNeich Medical Group Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

OrbusNeich Medical Group Holdings's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(352.011	-	0)	/	827.767
	=	0.43

OrbusNeich Medical Group Holdings's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(147.047	-	0)	/	826.601
	=	0.18

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.37

OrbusNeich Medical Group Holdings (HKSE:06929) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

OrbusNeich Medical Group Holdings EPS (Basic) Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

OrbusNeich Medical Group Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (HKSE:06929) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG

Website

https://www.orbusneich.com

OrbusNeich is a China-based global medical device maker of endovascular interventional instruments with global reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's largest revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its largest product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

Executives

Harmony Tree Limited	2101 Beneficial owner
Shenzhen Capital Group Co., Ltd.	2201 Interest of corporation controlled by you
Suzhou Red Earth Yeju Investment Ltd.	2101 Beneficial owner
Chien David	2201 Interest of corporation controlled by you
Lau Kwai Ching Denise	2201 Interest of corporation controlled by you
Shen Chuang Tou Zhi Zao Ye Zhuan Xing Sheng Ji Xin Cai Liao Ji Jin You Xian He Huo	2201 Interest of corporation controlled by you
Shen Chuang Tou Hong Tu Si Mu Gu Quan Tou Zi Ji Jin Guan Li Shen Zhen You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Hong Tu Ye Ju Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you

OrbusNeich Medical Group Holdings Headlines

No Headlines